Literature DB >> 12682473

Prolonged alveolocapillary barrier damage after acute cardiogenic pulmonary edema.

Carmine G De Pasquale1, Leonard F Arnolda, Ian R Doyle, Robyn L Grant, Phillip E Aylward, Andrew D Bersten.   

Abstract

OBJECTIVES: To determine whether acute cardiogenic pulmonary edema is associated with damage to the alveolocapillary barrier, as evidenced by increased leakage of surfactant specific proteins into the circulation, to document the duration of alveolocapillary barrier damage in this setting, and to explore the role of pulmonary parenchymal inflammation by determining if circulating tumor necrosis factor-alpha is increased after acute cardiogenic pulmonary edema.
DESIGN: Prospective, observational study.
SETTING: Critical care, cardiac intensive care, and cardiology wards of a tertiary-care university teaching hospital. PATIENTS: A total of 28 patients presenting with acute cardiogenic pulmonary edema and 13 age-matched normal volunteers.
INTERVENTIONS: Circulating surfactant protein-A and -B and tumor necrosis factor-alpha were measured on days 0 (presentation), 1, 3, 7, and 14. Clinical markers of pulmonary edema were documented at the same times.
MEASUREMENTS AND MAIN RESULTS: Surfactant protein-A and -B were elevated on day 0 compared with controls (367 +/- 17 ng/mL vs. 303 +/- 17 and 3821 +/- 266 ng/mL vs. 2747 +/- 157 [mean +/- sem], p <.05), and although clinical, hemodynamic and radiographic variables improved rapidly (p <.001), surfactant protein-A and -B rose further until day 3 (437 +/- 22, p <.001, 4642 +/- 353, p <.01). Tumor necrosis factor-alpha was elevated at presentation (p <.05), doubled by day 1 (6.98 +/- 1.36 pg/mL, p <.05), remained elevated on day 3 (5.72 +/- 0.96 pg/mL, p <.05), and peak levels were related to chest radiograph extravascular lung water score (r(p) = 0.64, p =.003).
CONCLUSIONS: Although the initial increase in plasma surfactant protein-A and -B may represent hydrostatic stress failure of the alveolocapillary barrier, the prolonged elevation, when hemodynamic abnormalities have resolved, and the delayed elevation of tumor necrosis factor-alpha are consistent with pulmonary parenchymal inflammation, which may further damage the alveolocapillary barrier. This prolonged physiologic defect at the alveolocapillary barrier after acute cardiogenic pulmonary edema may partly account for the vulnerability of these patients to recurrent pulmonary fluid accumulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682473     DOI: 10.1097/01.CCM.0000059649.31659.22

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

Review 1.  Fluid and electrolyte overload in critically ill patients: An overview.

Authors:  Bruno Adler Maccagnan Pinheiro Besen; André Luiz Nunes Gobatto; Lívia Maria Garcia Melro; Alexandre Toledo Maciel; Marcelo Park
Journal:  World J Crit Care Med       Date:  2015-05-04

Review 2.  Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Jessica H Huston; Sanjiv J Shah
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

3.  Biopsy-proven pulmonary determinants of heart disease.

Authors:  Felipe Muniz de Castro Zampieri; Edwin Roger Parra; Mauro Canzian; Leila Antonângelo; Bráulio Luna Filho; Carlos Roberto Ribeiro de Carvalho; Ronaldo Adib Kairalla; Vera Luiza Capelozzi
Journal:  Lung       Date:  2009-10-28       Impact factor: 2.584

Review 4.  Vascular endothelial growth factors in pulmonary edema: an update.

Authors:  Ioanna Kosmidou; Dimitrios Karmpaliotis; Ajay J Kirtane; Hal V Barron; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2007-06-07       Impact factor: 2.300

Review 5.  Lung morphology and surfactant function in cardiogenic pulmonary edema: a narrative review.

Authors:  Kenneth Nugent; Logan Dobbe; Rubayat Rahman; Mohamed Elmassry; Pablo Paz
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

6.  Surfactant-derived proteins as markers of alveolar membrane damage in heart failure.

Authors:  Paola Gargiulo; Cristina Banfi; Stefania Ghilardi; Damiano Magrì; Marta Giovannardi; Alice Bonomi; Elisabetta Salvioni; Elisa Battaia; Pasquale Perrone Filardi; Elena Tremoli; Piergiuseppe Agostoni
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

7.  Prolonged Respiratory Failure Following Acute Myocardial Infarction: A Case Report.

Authors:  Gayatri G Harshe; Sushama K Jotkar
Journal:  Cardiol Res       Date:  2011-03-25

8.  Comparison of two non-bronchoscopic methods for evaluating inflammation in patients with acute hypoxaemic respiratory failure.

Authors:  Giuseppe Colucci; Guido Domenighetti; Roberto Della Bruna; Josè Bonilla; Costanzo Limoni; Michael A Matthay; Thomas R Martin
Journal:  Crit Care       Date:  2009-08-11       Impact factor: 9.097

9.  Lungs in heart failure.

Authors:  Anna Apostolo; Giuliano Giusti; Paola Gargiulo; Maurizio Bussotti; Piergiuseppe Agostoni
Journal:  Pulm Med       Date:  2012-12-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.